Daiichi Sankyo is the second largest pharma company in Japan, developing small molecules & biologics for various diseases and was came into existence in 2005, through the merger of Sankyo Co., Ltd. and Daiichi Pharmaceutical Co., Ltd.
[stock_market_widget type=”comparison” template=”basic2″ color=”#5679FF” assets=”4568.T,4503.T,ESALF,TAK” fields=”name,change_abs,change_pct,volume,dividend_yield,eps,pe_ratio,shares_outstanding,market_cap,chart” links=”{‘4568.T’:{},’4503.T’:{},’ESALF’:{},’TAK’:{}}” api=”yf” chart_range=”1y” chart_interval=”1d”]
Stock Performance of Daiichi Sankyo & Company Vs Global Peers
Page 3 of 3
